Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

M. Wijtmans; R. Leurs; I.J.P. de Esch

doi:10.1517/13543784.16.7.967

Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

M. Wijtmans, R. Leurs, I.J.P. de Esch

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

The neurotransmitter histamine exerts its action through four distinct histamine receptors. The histamine H

Original language	English
Pages (from-to)	967-85
Journal	Expert Opinion on Investigational Drugs
Volume	16
Issue number	7
DOIs	https://doi.org/10.1517/13543784.16.7.967
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1517/13543784.16.7.967

Persistent URL (handle)

Persistent link

Cite this

@article{69d14e2528c248d1b09612c06a170efc,

title = "Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas",

abstract = "The neurotransmitter histamine exerts its action through four distinct histamine receptors. The histamine H",

author = "M. Wijtmans and R. Leurs and {de Esch}, I.J.P.",

year = "2007",

doi = "10.1517/13543784.16.7.967",

language = "English",

volume = "16",

pages = "967--85",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

TY - JOUR

T1 - Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

AU - Wijtmans, M.

AU - Leurs, R.

AU - de Esch, I.J.P.

PY - 2007

Y1 - 2007

N2 - The neurotransmitter histamine exerts its action through four distinct histamine receptors. The histamine H

AB - The neurotransmitter histamine exerts its action through four distinct histamine receptors. The histamine H

U2 - 10.1517/13543784.16.7.967

DO - 10.1517/13543784.16.7.967

M3 - Article

SN - 1354-3784

VL - 16

SP - 967

EP - 985

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

IS - 7

ER -

Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

Abstract

UN SDGs

Access to Document

Persistent URL (handle)

Fingerprint

Cite this